Universidad Peruana Cayetano Heredia
Quantitative (1)H Nuclear Magnetic Resonance Assay for the Rapid Detection of Pyrazinamide Resistance in Mycobacterium tuberculosis from Sputum Samples.
JavaScript is disabled for your browser. Some features of this site may not work without it.
Mostrar el registro sencillo del ítem
| dc.contributor.author | Lopez, Juan M. | |
| dc.contributor.author | Zimic-Peralta, Mirko Juan | |
| dc.contributor.author | Vallejos, Katherine | |
| dc.contributor.author | Sevilla, Diego | |
| dc.contributor.author | Quispe-Carbajal, Mariella | |
| dc.contributor.author | Roncal Ríos, Elisa del Rocío | |
| dc.contributor.author | Rodríguez Puma, Joseline | |
| dc.contributor.author | Rodríguez Quero, Jhojailith Yetzibith | |
| dc.contributor.author | Antiparra Villa, Ricardo Alfonso | |
| dc.contributor.author | Arteaga Pillaca, Héctor Jesús | |
| dc.contributor.author | Gilman, Robert H. | |
| dc.contributor.author | Maruenda, Helena | |
| dc.contributor.author | Sheen Cortavarria, Patricia | |
| dc.coverage.spatial | Hospital Nacional Hipólito Unánue, Lima, Perú | |
| dc.coverage.spatial | Laboratorio de Referencia Regional de Tuberculosis, Callao, Perú | |
| dc.date.accessioned | 2023-05-19T14:08:33Z | |
| dc.date.available | 2023-05-19T14:08:33Z | |
| dc.date.issued | 2023 | |
| dc.identifier.uri | https://hdl.handle.net/20.500.12866/13521 | |
| dc.description.abstract | Tuberculosis (TB), caused by Mycobacterium tuberculosis, is one of the 10 leading killer diseases in the world. At least one-quarter of the population has been infected, and there are 1.3 million deaths annually. The emergence of multidrug-resistant (MDR) and extensively drug-resistant (XDR) strains challenges TB treatments. One of the drugs widely used in first- and second-line regimens is pyrazinamide (PZA). Statistically, 50% of MDR and 90% of XDR clinical strains are resistant to PZA, and recent studies have shown that its use in patients with PZA-resistant strains is associated with higher mortality rates. Therefore, the is an urgent need for the development of an accurate and efficient PZA susceptibility assay. PZA crosses the M. tuberculosis membrane and is hydrolyzed to its active form, pyrazinoic acid (POA), by a nicotinamidase encoded by the pncA gene. Up to 99% of clinical PZA-resistant strains have mutations in this gene, suggesting that this is the most likely mechanism of resistance. However, not all pncA mutations confer PZA resistance, only the ones that lead to limited POA production. Therefore, susceptibility to PZA may be addressed simply by its ability to form, or not, POA. Here, we present a nuclear magnetic resonance method to accurately quantify POA directly in the supernatant of sputum cultures collected from TB patients. The ability of the clinical sputum culture to hydrolyze PZA was determined, and the results were correlated with the results of other biochemical and molecular PZA drug susceptibility assays. The excellent sensitivity and specificity values attained suggest that this method could become the new gold standard for the determination of PZA susceptibility. | en_US |
| dc.language.iso | eng | |
| dc.publisher | American Society for Microbiology | |
| dc.relation.ispartofseries | Journal of Clinical Microbiology | |
| dc.rights | info:eu-repo/semantics/restrictedAccess | |
| dc.rights.uri | https://creativecommons.org/licenses/by-nc-nd/4.0/deed.es | |
| dc.subject | tuberculosis | en_US |
| dc.subject | pyrazinamide | en_US |
| dc.subject | drug susceptibility test | en_US |
| dc.subject | clinical trial | en_US |
| dc.subject | nuclear magnetic resonance | en_US |
| dc.subject | Mycobacterium tuberculosis | en_US |
| dc.subject | antibiotic resistance | en_US |
| dc.subject.mesh | Tuberculosis | |
| dc.subject.mesh | Pirazinamida | |
| dc.subject.mesh | Pruebas de Sensibilidad Microbiana | |
| dc.subject.mesh | Ensayo Clínico | |
| dc.subject.mesh | Espectroscopía de Resonancia Magnética | |
| dc.subject.mesh | Mycobacterium tuberculosis | |
| dc.subject.mesh | Farmacorresistencia Microbiana | |
| dc.title | Quantitative (1)H Nuclear Magnetic Resonance Assay for the Rapid Detection of Pyrazinamide Resistance in Mycobacterium tuberculosis from Sputum Samples. | en_US |
| dc.type | info:eu-repo/semantics/article | |
| dc.identifier.doi | https://doi.org/10.1128/jcm.01522-22 | |
| dc.relation.issn | 1098-660X |
Ficheros en el ítem
| Ficheros | Tamaño | Formato | Ver |
|---|---|---|---|
|
No hay ficheros asociados a este ítem. |
|||
Este ítem aparece en la(s) siguiente(s) colección(ones)
-
Artículos en revistas indizadas [4988]
Recuperados de bases de datos bibliográficas
Excepto si se señala otra cosa, la licencia del ítem se describe como info:eu-repo/semantics/restrictedAccess
